SARS CoV 2 News and Research

RSS

An oral pill for COVID-19? Molnupiravir shows promise

Recently, researchers reported molnupiravir as the first oral and direct-acting antiviral that is highly effective at reducing SARS-CoV-2 levels.

27 Jun 2021

Swedish study reveals how long immunity lasts after mild COVID

As a result of the ongoing pandemic of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, the coronavirus disease 2019 (COVID-19), the global public health at risk has never been more dire.

27 Jun 2021

Why is staying active important during the COVID-19 pandemic?

Working from home is no excuse to stop exercising. New research led by Akira Ogami from the University of Occupational and Environmental Health in Japan confirms that regular exercise is needed in maintaining good physical and mental health during the COVID-19 pandemic. Workers who allocated time towards exercise or some form of physical activity reported a higher health-related quality of life than people who did not.

27 Jun 2021

Oxford study sheds light on level of antibodies needed to protect against COVID-19 symptoms

Researchers in the UK have reported on the relationship between humoral (antibody) responses and protection against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) following immunization with AstraZeneca’s ChAdOx1 vaccine.

27 Jun 2021

Lambda lineage of SARS-CoV-2 has potential to become variant of concern

Researchers have described the first reported infection with the C.37 (Lambda) lineage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Southern Brazil.

27 Jun 2021

Structural studies of SARS-CoV-2 spike protein reveal new properties of Alpha and Beta variants

New SARS-CoV-2 variants are spreading rapidly, and there are fears that current COVID-19 vaccines won't protect against them.

25 Jun 2021

SARS-CoV-2 virus sequences could be identified from hospital surface swabs

A new study by UC Davis researchers confirms the low likelihood that SARS-CoV-2 contamination on hospital surfaces is infectious.

25 Jun 2021

Novel biosensor offers rapid quantitative variant of concern-independent serology for SARS-CoV-2

Even as herculean efforts are being made to extend the reach of vaccination against COVID-19 to all the regions of the world, there is a dire need for rapid and sensitive tests to assess the antibody response to the various vaccines used and to monitor antibody titers over time. A new preprint describes a new approach to this problem which could be applied to other molecules of interest as well, both in laboratories and at the point of care.

25 Jun 2021

Study examines safety of COVID-19 vaccination during lactation

A new preprint, recently released on the medRxiv* server, reports from real life in a cohort of mother-child dyads in Singapore. The mothers were lactating after having received COVID-19 vaccination.

25 Jun 2021

Evaluation of COVID-19 vaccination effects on outbreak dynamics in Japan

Among the developed nations, Japan was the last to commence vaccination (February 2021). Only 8.7% of Japanese people are fully vaccinated as of today, June 25th, 2021. Fortunately for Japan, the incidence of the disease has been much lower than in Europe or the United States. Now, a new study published on the medRxiv* preprint server analyzes the impact of vaccination on the COVID-19 outbreak in Japan

25 Jun 2021

Multisystem Inflammatory Syndrome in Children significantly affects more Black and Latino children

Multisystem Inflammatory Syndrome in Children (MIS-C) significantly affected more Black and Latino children than white children, with Black children at the highest risk, according to a new observational study of 124 pediatric patients treated at Children's National Hospital in Washington, D.C.

25 Jun 2021

Researchers model infection-spreading scenarios to understand the impact of COVID-19

Researchers at the Niels Bohr Institute, University of Copenhagen, together with epidemiologist Lone Simonsen from Roskilde University form part of the panel advising the Danish government on how to tackle the different infection-spreading situations we have all seen unfold over the past year.

25 Jun 2021

Nanobodies with drug-like properties can prevent COVID-19 infection

Discovering and engineering nanobodies with properties suitable for treating human diseases ranging from cancer to COVID-19 is a time-consuming, laborious process.

25 Jun 2021

Overcrowding and multigenerational housing arrangements increase SARS-CoV-2 transmission risk

Researchers at the Weill Cornell Medical College aimed to determine the role of overcrowded households as a risk factor for COVID-19. The study's objective, which appeared in the medRxiv* pre-print server, was to examine the link between overcrowded and multigenerational households and COVID-19 in New York City.

25 Jun 2021

Renowned scientists recover deleted SARS-CoV-2 data from Wuhan

Renowned evolutionary researcher, Jesse Bloom from the Fred Hutchinson Cancer Research Center, has conducted a phylogenetic analysis suggesting that the early severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequences that were obtained from the Huanan Seafood Market in Wuhan, China, are not fully representative of the viruses circulating in the city at the time of the coronavirus disease 2019 (COVID-19) outbreak.

24 Jun 2021

Study shows how SARS-CoV-2 virus enters cells to cause infection

Early in the COVID-19 pandemic, scientists identified how SARS-CoV-2, the virus that causes COVID-19, gets inside cells to cause infection.

24 Jun 2021

Phenomenological model describes and regularizes COVID-19 data

The COVID-19 epidemic, which began late December 2019 in Wuhan, China, and rapidly spread throughout the world, was accompanied by unprecedented releases of reported case data. Now, researchers propose combining phenomenological descriptions with epidemiological dynamics for an entirely new perspective on these data.

24 Jun 2021

SARS CoV 2 News and Research

An oral pill for COVID-19? Molnupiravir shows promise

Swedish study reveals how long immunity lasts after mild COVID

Why is staying active important during the COVID-19 pandemic?

Oxford study sheds light on level of antibodies needed to protect against COVID-19 symptoms

Lambda lineage of SARS-CoV-2 has potential to become variant of concern

Structural studies of SARS-CoV-2 spike protein reveal new properties of Alpha and Beta variants

SARS-CoV-2 virus sequences could be identified from hospital surface swabs

Novel biosensor offers rapid quantitative variant of concern-independent serology for SARS-CoV-2

Study examines safety of COVID-19 vaccination during lactation

Evaluation of COVID-19 vaccination effects on outbreak dynamics in Japan

Multisystem Inflammatory Syndrome in Children significantly affects more Black and Latino children

Researchers model infection-spreading scenarios to understand the impact of COVID-19

Nanobodies with drug-like properties can prevent COVID-19 infection

Overcrowding and multigenerational housing arrangements increase SARS-CoV-2 transmission risk

Renowned scientists recover deleted SARS-CoV-2 data from Wuhan

Study shows how SARS-CoV-2 virus enters cells to cause infection

Phenomenological model describes and regularizes COVID-19 data

Researchers develop a low-cost automated rapid test for detecting SARS-CoV-2 antibodies

Pronation maneuvers for critically ill COVID-19 patients - multidisciplinary management reduce complications

Mask-wearing reduces COVID-19 transmission significantly, study finds

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News